BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38444261)

  • 21. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Parameters of
    Yang J; Zhu S; Pang F; Xu M; Dong Y; Hao J; Ma X
    Contrast Media Mol Imaging; 2018; 2018():8659826. PubMed ID: 30363729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomics Analysis of [
    Ceriani L; Milan L; Virili C; Cascione L; Paone G; Trimboli P; Giovanella L
    Thyroid; 2021 Jan; 31(1):88-95. PubMed ID: 32517585
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
    Hwang JW; Jee SR; Lee SH; Kim JH; Seol SY; Lee SM
    Korean J Gastroenterol; 2016 Apr; 67(4):183-8. PubMed ID: 27112244
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Albano D; Durmo R; Treglia G; Giubbini R; Bertagna F
    Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):137-146. PubMed ID: 32029397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG avidity and PET/CT patterns in primary gastric lymphoma.
    Radan L; Fischer D; Bar-Shalom R; Dann EJ; Epelbaum R; Haim N; Gaitini D; Israel O
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1424-30. PubMed ID: 18418594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.
    Albano D; Bosio G; Treglia G; Giubbini R; Bertagna F
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):77-84. PubMed ID: 28822997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline [
    Yang Q; Luo Y; Zhang Y; Zhang W; Zhou D; Li F
    Eur Radiol; 2022 Aug; 32(8):5568-5576. PubMed ID: 35316362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of baseline
    Dondi F; Albano D; Bellini P; Cerudelli E; Treglia G; Bertagna F
    Clin Imaging; 2023 Feb; 94():71-78. PubMed ID: 36495848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
    Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
    World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.
    Peng Y; Qi W; Luo Z; Zeng Q; Huang Y; Wang Y; Sharma A; Schmidt-Wolf IGH; Liao F
    Front Oncol; 2022; 12():973109. PubMed ID: 36185301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
    Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients.
    Albano D; Mazzoletti A; Spallino M; Muzi C; Zilioli VR; Pagani C; Tucci A; Rossetti C; Giubbini R; Bertagna F
    Ann Hematol; 2020 Jun; 99(6):1321-1330. PubMed ID: 32333153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-FDG PET/CT in splenic marginal zone lymphoma.
    Albano D; Giubbini R; Bertagna F
    Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation.
    Albano D; Bosio G; Giubbini R; Bertagna F
    Leuk Lymphoma; 2017 Oct; 58(10):2328-2334. PubMed ID: 28270020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist.
    Albano D; Bosio G; Tomasini D; Bonù M; Giubbini R; Bertagna F
    Asia Pac J Clin Oncol; 2020 Oct; 16(5):e207-e215. PubMed ID: 32762133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL; Liang JH; Wang L; Xu W; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of
    Wang W; Ni X; Tang T; Wang J; Li Y; Song X
    Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic Value of
    Su JM; Zheng QZ; Huang WR; Deng J; Wu J; Lu HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1181-1186. PubMed ID: 34362500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.